Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Cancer”

441 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 441 results

Not applicableStudy completedNCT03435536
What this trial is testing

Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
University Hospital, Toulouse 35
Testing effectiveness (Phase 2)WithdrawnNCT00728000
What this trial is testing

Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Cincinnati
Not applicableLooking for participantsNCT05052671
What this trial is testing

CtDNA Assay in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreas Cancer
University of Oklahoma 50
Early research (Phase 1)Looking for participantsNCT06673017
What this trial is testing

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma+1 more
PanTher Therapeutics 26
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Large-scale testing (Phase 3)Study completedNCT03984214
What this trial is testing

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic
Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Not applicableTemporarily pausedNCT06375967
What this trial is testing

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Who this might be right for
Malignant Biliary ObstructionBiliary Tract NeoplasmsPancreatic Cancer Non-resectable
Hospital Universitari de Bellvitge 128
Testing effectiveness (Phase 2)UnknownNCT06345300
What this trial is testing

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

Who this might be right for
Borderline Resectable Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Early research (Phase 1)Looking for participantsNCT07024615
What this trial is testing

ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Global Development, Inc. 25
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Large-scale testing (Phase 3)UnknownNCT04617821
What this trial is testing

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
Fudan University 300
Early research (Phase 1)Ended earlyNCT02707328
What this trial is testing

Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)

Who this might be right for
Pancreas CancerPancreatic CancerAdenocarcinoma of the Pancreas+2 more
The Cooper Health System 30
Not applicableUnknownNCT00079365
What this trial is testing

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of South Florida
Testing effectiveness (Phase 2)Study completedNCT02125136
What this trial is testing

Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Ductal Adenocarcinoma of the Pancreas
AIO-Studien-gGmbH 168
Early research (Phase 1)Ended earlyNCT00892242
What this trial is testing

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer

Who this might be right for
Adenocarcinoma
Washington University School of Medicine 24
Testing effectiveness (Phase 2)WithdrawnNCT00487851
What this trial is testing

Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract NeoplasmsDuodenal Neoplasms
Karolinska Institutet
Early research (Phase 1)UnknownNCT02599662
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreas Cancer

Who this might be right for
Pancreas Cancer
Loyola University 12
Early research (Phase 1)Study completedNCT00985777
What this trial is testing

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 26
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Next Page